| Analysis of serological biomarkers of SARS-CoV-2 infection in convalescent samples from severe, moderate and mild COVID-19 cases J Castillo-Olivares, DA Wells, M Ferrari, ACY Chan, P Smith, ... Frontiers in Immunology 12, 748291, 2021 | 29 | 2021 |
| MYC regulates a pan-cancer network of co-expressed oncogenic splicing factors L Urbanski, M Brugiolo, SH Park, BL Angarola, NK Leclair, M Yurieva, ... Cell reports 41 (8), 2022 | 21 | 2022 |
| Towards Internationally standardised humoral Immune Correlates of Protection from SARS-CoV-2 infection and COVID-19 disease J Castillo-Olivares, DA Wells, M Ferrari, A Chan, P Smith, ... medRxiv, 2021.05. 21.21257572, 2021 | 17 | 2021 |
| Neutralisation hierarchy of SARS-CoV-2 variants of concern using standardised, quantitative neutralisation assays reveals a correlation with disease severity; towards … D Cantoni, M Mayora-Neto, A Nadesalingam, DA Wells, GW Carnell, ... Frontiers in immunology 13, 773982, 2022 | 15 | 2022 |
| AutoPlate: rapid dose-response curve analysis for biological assays P Palmer, JMM Del Rosario, KAS da Costa, GW Carnell, CQ Huang, ... Frontiers in Immunology 12, 681636, 2022 | 2 | 2022 |
| Standardised, quantitative neutralisation responses to SARS-CoV-2 Variants of Concern by convalescent anti-sera from first wave infections of UK Health Care Workers and Patients. D Cantoni, M Mayora-Neto, A Nadesalingham, DA Wells, GW Carnell, ... medRxiv, 2021 | 1 | 2021 |
